ArticleBMJ open2023

Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers.

Sigrid Lundgren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.